Interventional Cardiology Devices Market Report

Date: 1 August 2019

A research report published by Azoth Analytics in July 2019 suggests that the Interventional Cardiovascular Devices Market was valued at USD 11.50 billion in the year 2018. Some of the significant responsible factors for high demand of such innovative medical devices include rise in the incidence of chronic diseases, increase in geriatric population as well as growing number of individuals leading a sedentary lifestyle.

The Azoth Analytics research report titled Global Interventional Cardiovascular Devices Market has analysed and segmented the Interventional Cardiovascular Devices Market. The report has analysed the Interventional Cardiovascular Devices Market by Product Type (Catheter, Stent, Balloon, Guidewire, and Systems) on the global, regional as well as country level. The Global Interventional Cardiovascular Devices Market has been analysed By Region (North America, Europe, APAC and Rest of the World) and By Country (United States, Canada, United Kingdom, Germany, Japan, China, India and Brazil) for the historical period of 2014-2018 and the forecast period of 2019-2024.

The most important determinant of cardiovascular health is a person’s age. As per the recent reports published by the World Health Organization, the proportion of the world’s population over 60 years will double from 12% to 22% between 2015 and 2050. In this age group, cardiovascular diseases (CVD) will result in approximately 40% of all deaths. Thereby, ranking as the leading cause of mortality. Furthermore, the cost to treat complex cardiovascular ailments is anticipated to triple in that time. As a consequence, contributing significantly to the increased demand of interventional cardiovascular procedures. Besides, development of patient friendly techniques and increasing awareness about minimally invasive procedures among patients and medical practitioners alike is highly likely to substantiate the demand of interventional cardiovascular procedures globally. 

Highly developed economies such as United States, Canada, United Kingdom, Germany, etc., have a highly advanced landscape of medical infrastructure along with substantially high per capita expenditure on healthcare. Additionally, the penetration of medical insurance among consumers in these countries is also remarkably high in comparison with Asia Pacific or Latin America. In light of these encouraging aspects, the North America region possessed majority shares in the global interventional cardiovascular devices market, followed by Europe. What is more, presence of vast number of cardiovascular device manufacturers such as Medtronic, Edward Lifesciences, Cardinal Health, Boston Scientific Corporation, Abbott Laboratories, among others have made the regional markets intensely competitive. On the other hand, swiftly emerging countries in the APAC region including China and India showcased promising growth potential in the historic period.